Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Clin Cancer Res. 2016 Oct 25;23(10):2516–2527. doi: 10.1158/1078-0432.CCR-16-1834

Figure 1.

Figure 1

5T4 oncofetal antigen is expressed in HNSCC and correlates with overall survival. (A) Immunohistochemistry staining for 5T4 in human HNSCC tumor cores. Images are representative of staining patterns in 5T4-low and 5T4-high groups, as well as 5T4 expression in normal human oral mucosa control tissue. (B) Graph depicting overall survival over time in tumors with high and low 5T4 expression. (C) Graph depicting the breakdown of 5T4-low and 5T4-high tumors by disease stage at time of diagnosis.